Literature DB >> 26819048

Frequency, distribution and clinical management of incidental findings and extramedullary plasmacytomas in whole body diffusion weighted magnetic resonance imaging in patients with multiple myeloma.

Anita Wale1, Charlotte Pawlyn2, Martin Kaiser2, Christina Messiou3.   

Abstract

Entities:  

Keywords:  extramedullary; incidental findings; multiple myeloma; plasmacytoma; whole body MRI

Mesh：

Year:  2016        PMID： 26819048      PMCID： PMC5004402          DOI： 10.3324/haematol.2015.139816

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  9 in total

1.  Whole-body MRI in neurofibromatosis: incidental findings and prevalence of scoliosis.

Authors:  Jacob L Jaremko; Peter J MacMahon; Martin Torriani; Vanessa L Merker; Victor F Mautner; Scott R Plotkin; Miriam A Bredella
Journal:  Skeletal Radiol       Date:  2011-12-07       Impact factor: 2.199

Review 2.  Incidental findings in imaging diagnostic tests: a systematic review.

Authors:  B Lumbreras; L Donat; I Hernández-Aguado
Journal:  Br J Radiol       Date:  2010-04       Impact factor: 3.039

3.  Can whole-body magnetic resonance imaging with diffusion-weighted imaging replace Tc 99m bone scanning and computed tomography for single-step detection of metastases in patients with high-risk prostate cancer?

Authors:  Frédéric E Lecouvet; Jawad El Mouedden; Laurence Collette; Emmanuel Coche; Etienne Danse; François Jamar; Jean-Pascal Machiels; Bruno Vande Berg; Patrick Omoumi; Bertrand Tombal
Journal:  Eur Urol       Date:  2012-02-17       Impact factor: 20.096

4.  Bone metastases from prostate, breast and multiple myeloma: differences in lesion conspicuity at short-tau inversion recovery and diffusion-weighted MRI.

Authors:  T Pearce; S Philip; J Brown; D M Koh; P R Burn
Journal:  Br J Radiol       Date:  2012-03-28       Impact factor: 3.039

Review 5.  Whole-body diffusion-weighted MR imaging in cancer: current status and research directions.

Authors:  Anwar R Padhani; Dow-Mu Koh; David J Collins
Journal:  Radiology       Date:  2011-12       Impact factor: 11.105

6.  Role of magnetic resonance imaging in the management of patients with multiple myeloma: a consensus statement.

Authors:  Meletios A Dimopoulos; Jens Hillengass; Saad Usmani; Elena Zamagni; Suzanne Lentzsch; Faith E Davies; Noopur Raje; Orhan Sezer; Sonja Zweegman; Jatin Shah; Ashraf Badros; Kazuyuki Shimizu; Philippe Moreau; Chor-Sang Chim; Juan José Lahuerta; Jian Hou; Artur Jurczyszyn; Hartmut Goldschmidt; Pieter Sonneveld; Antonio Palumbo; Heinz Ludwig; Michele Cavo; Bart Barlogie; Kenneth Anderson; G David Roodman; S Vincent Rajkumar; Brian G M Durie; Evangelos Terpos
Journal:  J Clin Oncol       Date:  2015-01-20       Impact factor: 44.544

7.  Incidental findings in healthy control research subjects using whole-body MRI.

Authors:  S H X Morin; J F L Cobbold; A K P Lim; J Eliahoo; E L Thomas; S R Mehta; G Durighel; J Fitzpatrick; J D Bell; S D Taylor-Robinson
Journal:  Eur J Radiol       Date:  2008-09-24       Impact factor: 3.528

8.  Clinical value of whole-body magnetic resonance imaging in health screening of general adult population.

Authors:  David Laszlo Tarnoki; Adam Domonkos Tarnoki; Antje Richter; Kinga Karlinger; Viktor Berczi; Dirk Pickuth
Journal:  Radiol Oncol       Date:  2015-03-03       Impact factor: 2.991

Review 9.  Whole body diffusion weighted MRI--a new view of myeloma.

Authors:  Christina Messiou; Martin Kaiser
Journal:  Br J Haematol       Date:  2015-05-26       Impact factor: 6.998
  9 in total
  4 in total

1.  Whole-body magnetic resonance imaging (WB-MRI) with diffusion-weighted whole-body imaging with background body signal suppression (DWIBS) in prostate cancer: Prevalence and clinical significance of incidental findings.

Authors:  Soma Kumasaka; Shunichi Motegi; Yuka Kumasaka; Tatsuya Nishikata; Masami Otomo; Yoshito Tsushima
Journal:  Br J Radiol       Date:  2021-06-16       Impact factor: 3.039

Review 2.  Implementing diffusion-weighted MRI for body imaging in prospective multicentre trials: current considerations and future perspectives.

Authors:  N M deSouza; J M Winfield; J C Waterton; A Weller; M-V Papoutsaki; S J Doran; D J Collins; L Fournier; D Sullivan; T Chenevert; A Jackson; M Boss; S Trattnig; Y Liu
Journal:  Eur Radiol       Date:  2017-09-27       Impact factor: 5.315

3.  Detection of avascular necrosis on routine diffusion-weighted whole body MRI in patients with multiple myeloma.

Authors:  Naeem Ahmed; Priya Sriskandarajah; Christian Burd; Angela Riddell; Kevin Boyd; Martin Kaiser; Christina Messiou
Journal:  Br J Radiol       Date:  2019-02-12       Impact factor: 3.039

4.  MUKnine OPTIMUM protocol: a screening study to identify high-risk patients with multiple myeloma suitable for novel treatment approaches combined with a phase II study evaluating optimised combination of biological therapy in newly diagnosed high-risk multiple myeloma and plasma cell leukaemia.

Authors:  Sarah Brown; Debbie Sherratt; Matthew Jenner; Martin Kaiser; Samantha Hinsley; Louise Flanagan; Sadie Roberts; Katrina Walker; Andrew Hall; Guy Pratt; Christina Messiou
Journal:  BMJ Open       Date:  2021-03-24       Impact factor: 2.692
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.